Repatha 140 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DB25FVLC8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,338
Award facts
- Contract value 100% obligated
- $18,338.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,338.15 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of September 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as one of the nation's largest pharmaceutical distributors.
This delivery order falls under AmerisourceBergen's comprehensive $999.999 billion indefinite delivery contract (SPE2DX) with DLA Troop Support Medical, which extends through December 2026 and serves as the primary vehicle for pharmaceutical and medical supply procurement across military healthcare systems globally. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a broad range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare products to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare programs. Repatha is a PCSK9 inhibitor indicated for cardiovascular disease management, and this auto-injector formulation provides a convenient delivery mechanism for patients requiring ongoing treatment within the military health system.
Quick answers
Who was awarded contract SPE2DB25FVLC8?
SPE2DB25FVLC8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 11, 2025.
How much is contract SPE2DB25FVLC8 worth?
The government has obligated $18,338 on SPE2DB25FVLC8.
Is contract SPE2DB25FVLC8 an order under another contract?
Yes. SPE2DB25FVLC8 is a delivery order under SPE2DB22D1202, an indefinite delivery contract.
Was contract SPE2DB25FVLC8 competed?
The extent of competition for SPE2DB25FVLC8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award